The SARS-CoV-2 B. 1.617. 2 Delta variant of concern (VOC) continues to drive a sharp increase
in COVID-19 cases in the UK, with a current doubling time of 3· 5–16 days, 1 consistent …

We sought to compare neutralising antibody responses between seronaive haemodialysis
patients and the healthy individuals we have already reported on as part of the Legacy study. …

Elsevier, The Lancet’s publisher, con tinues to subsidise climate pollution through analytic
tools and new jour nals supporting coal, oil, and gas explo ration and extraction—an ongoing …

Omicron, the SARS-CoV-2 B. 1.1. 529 variant of concern (VOC), was first detected in southern
Africa in November, 2021, and its BA. 1 sublineage is now dominant in the UK. Omicron …

Background Although mainly causing a respiratory syndrome, numerous neurological symptoms
have been identified following of SARS-CoV-2 infection. However, how the virus affects …

During the autumn of 2022, both the US Centers for Disease Control and Prevention and
the UK’s Joint Committee on Vaccination and Immunisation recommended the targeted …

Most patients with blood cancer have reduced humoral and cellular immunity against SARS-CoV-2
variants following COVID-19 vaccination 1, 2, so are at increased risk of severe …

We describe a Sanger sequencing protocol for SARS‐CoV‐2 S‐gene the Spike (S)‐glycoprotein
product of which, composed of receptor‐binding (S1) and membrane fusion (S2) …

Porcine deltacoronavirus (PDCoV) was first identified in Hong Kong in 2012 from samples
taken from pigs in 2009. PDCoV was subsequently identified in the USA in 2014 in pigs with a …

The emergence of successive SARS-CoV-2 variants of concern (VOC) during 2020-22, each
exhibiting increased epidemic growth relative to earlier circulating variants, has created a …